Jennifer Murphy, DO
Interventional Pain Medicine · Ashland, KYNPI 1588124218
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,939 of the $4,633 with a category attached, or 63.4%. 13 manufacturers reported payments, led by Medtronic at 35.5% of the total. Reporting peaked in 2023 at $2,148 and has fallen 66.0% since, to $731 in 2025.
Across 111 payments — averaging $41.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Nevro Corp.$487
- Si-bone, Inc.$220
- Painteq LLC$181
- Globus Medical$173
- plus $484 from 7 others
What the payments were for
- Travel & lodging$1,69437%
- Food & beverage$2,93963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 18 | $1,644 |
| Boston Scientific | 65 | $1,444 |
| Nevro Corp. | 6 | $487 |
| Si-bone, Inc. | 3 | $220 |
| Painteq LLC | 2 | $181 |
| Globus Medical | 3 | $173 |
| Merz Pharmaceuticals, LLC | 5 | $123 |
| Tersera Therapeutics LLC | 1 | $121 |
| Spinal Simplicity, LLC | 2 | $116 |
| AbbVie | 3 | $60 |
| Avanos Medical | 1 | $29 |
| Stryker | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VANTA ADAPTIVESTIM$995
- Senza$384
- PAINTEQ$166
- Vyrsa V1$148
- SYNCHROMEDII$138
- PRIALT$121
How this compares
$4,633 in reported general payments places this provider in the 65th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $780 |
| Gabapentin | 63 | $596 |
| Baclofen | 13 | $359 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $291 |
| Pregabalin | 16 | $248 |
| Duloxetine Hcl | 12 | $180 |
| Tizanidine Hcl | 16 | $87 |
| Diazepam | 20 | $12 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Ashland
- Robert KlickovichFlorence$57K
- Hammad MalikRichmond$35K
- Michael FletcherFlorence$18K
- Vishal BansalMadisonville$13K
- Anand ModaduguLexington$12K
- Zachary KlingerCorbin$10K
- Nathan LambornLouisville$10K
- Brock MarrsLexington$9K
- Brandon SuttonLouisville$9K
- Gary ReasorLouisville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.